A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4551-4555

  Kalmijn, S ^a   Janssen, J A M J L ^a   Pols, H A P ^a   Lamberts, S W J ^a   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; EDUCATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSYCHIATRIC DIAGNOSIS; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE; SINGLE BLIND PROCEDURE;

EID: 0034489209     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.12.7033     Document Type: Article

References (43)

1. Age related alterations of the growth hormone/insulin-like growth factor I axis
2. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus
3. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity
4. Insulin and insulin-like growth factor-I regulate tau phosphorylation in cultured human neurons
5. Quality of life and cognitive function in patients with pituitary insufficiency
6. Cognitive changes during growth hormone replacement in adult men
7. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency
8. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action and cognitive function
9. Insulin-like growth factor-I and cognitive function in healthy older men
10. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects
11. The role of insulin-like growth factor binding proteins and the IGFBP proteases in modulation of IGF action
12. Insulin-like growth factor binding proteins and their role in controlling IGF actions
13. Increased proteolysis of insulin-like growth factor binding protein (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29 kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130-150 kDa ternary complex
14. Insulin-like growth factor binding protein-I: Recent findings and new directions
15. Growth hormone determination in serum from patients with growth disorders
16. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
17. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: The possible role of insulin-like growth factor-binding protein-3 proteolysis
18. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour
19. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I
20. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
21. What do free IGF-I assays actually measure? Method validation using mathematical modeling
22. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study
23. "Mini-Mental State:" A practical method for grading the cognitive state of patients for the clinician
24. Overview of incidence studies of dementia conducted in Europe
25. Scoring nonresponse on the Mini-Mental State Examination
26. Screening for dementia and investigating its causes
27. Dietary assesment in the elderly: Validation of a semiquantitative food frequency questionnaire
28. The Mini-Mental state examination: A comprehensive review
29. Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type
30. Insulin-like growth factors and IGF-binding proteins: Their use for diagnosis of growth hormone deficiency
31. Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion
32. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I
33. Is free IGF-I more indicative than total IGF-I measurement to evaluate the activity of the GH/IGF-I axis?
34. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
35. Growth hormone replacement in healthy older men improves body composition but not functional ability
36. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency
37. Serum proteolysis of IGFBP-3
38. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly
39. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
40. Nutritional regulation of the insulin-like growth factors
41. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture
42. Amino acids and proteins in relation to the nutrition of elderly people
43. Nutritional status and cognitive functioning in a normally aging sample: A 6 year assessment